N-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine

C82H83F15N30O9S — CID 160875890

IUPACN-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine
SMILESCC(=O)N1CCC(Oc2cc(-c3cnc(N)nc3C(F)(F)F)nc(N3CCOCC3)n2)CC1.CC(=O)Nc1ncc(-c2cc(-c3cnc(N)cc3C(F)(F)F)nc(N3CCOCC3)n2)s1.Nc1ncc(-c2cc(-c3cnc(N)nc3C(F)(F)F)nc(N3CCOCC3)n2)c(C(F)(F)F)n1.Nc1ncc(-c2cc(OC3CCN(C(=O)c4ccccc4)CC3)nc(N3CCOCC3)n2)c(C(F)(F)F)n1
InChIInChI=1S/C25H26F3N7O3.C20H24F3N7O3.C19H18F3N7O2S.C18H15F6N9O/c26-25(27,28)21-18(15-30-23(29)33-21)19-14-20(32-24(31-19)35-10-12-37-13-11-35)38-17-6-8-34(9-7-17)22(36)16-4-2-1-3-5-16;1-12(31)29-4-2-13(3-5-29)33-16-10-15(26-19(27-16)30-6-8-32-9-7-30)14-11-25-18(24)28-17(14)20(21,22)23;1-10(30)26-18-25-9-15(32-18)14-7-13(27-17(28-14)29-2-4-31-5-3-29)11-8-24-16(23)6-12(11)19(20,21)22;19-17(20,21)12-8(6-27-14(25)31-12)10-5-11(30-16(29-10)33-1-3-34-4-2-33)9-7-28-15(26)32-13(9)18(22,23)24/h1-5,14-15,17H,6-13H2,(H2,29,30,33);10-11,13H,2-9H2,1H3,(H2,24,25,28);6-9H,2-5H2,1H3,(H2,23,24)(H,25,26,30);5-7H,1-4H2,(H2,25,27,31)(H2,26,28,32)
InChIKeySMJQOIUUNUTUNI-UHFFFAOYSA-N
MW1949.80 g/mol
LogP10.30
Rot. Bonds16

About N-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine

N-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine (PubChem CID 160875890) has the molecular formula C82H83F15N30O9S and a molecular weight of 1949.80 g/mol. Its IUPAC name is N-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine.

Molecular Properties

Compound NameN-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine
PubChem CID160875890
Molecular FormulaC82H83F15N30O9S
Molecular Weight1949.80 g/mol
Exact Mass1948.64
IUPAC NameN-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine
SMILESCC(=O)N1CCC(Oc2cc(-c3cnc(N)nc3C(F)(F)F)nc(N3CCOCC3)n2)CC1.CC(=O)Nc1ncc(-c2cc(-c3cnc(N)cc3C(F)(F)F)nc(N3CCOCC3)n2)s1.Nc1ncc(-c2cc(-c3cnc(N)nc3C(F)(F)F)nc(N3CCOCC3)n2)c(C(F)(F)F)n1.Nc1ncc(-c2cc(OC3CCN(C(=O)c4ccccc4)CC3)nc(N3CCOCC3)n2)c(C(F)(F)F)n1
InChIInChI=1S/C25H26F3N7O3.C20H24F3N7O3.C19H18F3N7O2S.C18H15F6N9O/c26-25(27,28)21-18(15-30-23(29)33-21)19-14-20(32-24(31-19)35-10-12-37-13-11-35)38-17-6-8-34(9-7-17)22(36)16-4-2-1-3-5-16;1-12(31)29-4-2-13(3-5-29)33-16-10-15(26-19(27-16)30-6-8-32-9-7-30)14-11-25-18(24)28-17(14)20(21,22)23;1-10(30)26-18-25-9-15(32-18)14-7-13(27-17(28-14)29-2-4-31-5-3-29)11-8-24-16(23)6-12(11)19(20,21)22;19-17(20,21)12-8(6-27-14(25)31-12)10-5-11(30-16(29-10)33-1-3-34-4-2-33)9-7-28-15(26)32-13(9)18(22,23)24/h1-5,14-15,17H,6-13H2,(H2,29,30,33);10-11,13H,2-9H2,1H3,(H2,24,25,28);6-9H,2-5H2,1H3,(H2,23,24)(H,25,26,30);5-7H,1-4H2,(H2,25,27,31)(H2,26,28,32)
InChIKeySMJQOIUUNUTUNI-UHFFFAOYSA-N
XLogP10.30
TPSA500.18 Ų
H-Bond Donors6
H-Bond Acceptors37
Rotatable Bonds16
Heavy Atoms137
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001949.80
LogP ≤ 510.30
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1037

Analyze N-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine?
The IUPAC name of N-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine (CID 160875890) is N-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine.
What is the SMILES notation for N-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine?
The canonical SMILES for N-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine is CC(=O)N1CCC(Oc2cc(-c3cnc(N)nc3C(F)(F)F)nc(N3CCOCC3)n2)CC1.CC(=O)Nc1ncc(-c2cc(-c3cnc(N)cc3C(F)(F)F)nc(N3CCOCC3)n2)s1.Nc1ncc(-c2cc(-c3cnc(N)nc3C(F)(F)F)nc(N3CCOCC3)n2)c(C(F)(F)F)n1.Nc1ncc(-c2cc(OC3CCN(C(=O)c4ccccc4)CC3)nc(N3CCOCC3)n2)c(C(F)(F)F)n1.
What is the InChIKey of N-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine?
The InChIKey is SMJQOIUUNUTUNI-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H26F3N7O3.C20H24F3N7O3.C19H18F3N7O2S.C18H15F6N9O/c26-25(27,28)21-18(15-30-23(29)33-21)19-14-20(32-24(31-19)35-10-12-37-13-11-35)38-17-6-8-34(9-7-17)22(36)16-4-2-1-3-5-16;1-12(31)29-4-2-13(3-5-29)33-16-10-15(26-19(27-16)30-6-8-32-9-7-30)14-11-25-18(24)28-17(14)20(21,22)23;1-10(30)26-18-25-9-15(32-18)14-7-13(27-17(28-14)29-2-4-31-5-3-29)11-8-24-16(23)6-12(11)19(20,21)22;19-17(20,21)12-8(6-27-14(25)31-12)10-5-11(30-16(29-10)33-1-3-34-4-2-33)9-7-28-15(26)32-13(9)18(22,23)24/h1-5,14-15,17H,6-13H2,(H2,29,30,33);10-11,13H,2-9H2,1H3,(H2,24,25,28);6-9H,2-5H2,1H3,(H2,23,24)(H,25,26,30);5-7H,1-4H2,(H2,25,27,31)(H2,26,28,32).
What are the key properties of N-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine?
N-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine has a molecular weight of 1949.80 g/mol, XLogP of 10.30, 16 rotatable bonds, 6 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-1,3-thiazol-2-yl]acetamide;1-[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]ethanone;[4-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]oxypiperidin-1-yl]-phenylmethanone;5-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine is sourced from PubChem (CID 160875890), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).